Information about Stouten Pharma Consultancy
My details
*
*
*

Stouten Pharma Consultancy (SRL)

Company information

Status
Active

Enterprise number

BE0800.893.564

VAT liability
Yes
Established
18-04-2023
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Stouten Pharma Consultancy

2024 2023
Profit/Loss 112,058 7553 % 1,464
Equity 133,522 522 % 21,464
Gross margin 159,450 4761 % 3,281

Publications from Stouten Pharma Consultancy

Date Publication
21-04-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Stouten Pharma Consultancy?
The VAT number of Stouten Pharma Consultancy is BE 0800.893.564.
Wat is the PEPPOL ID of Stouten Pharma Consultancy?
The PEPPOL ID of Stouten Pharma Consultancy is 0208:0800893564. Log in or start a free trial to see the full overview.
When was Stouten Pharma Consultancy founded?
Stouten Pharma Consultancy was founded on 18-04-2023.
What is the address of Stouten Pharma Consultancy?
The current registered office of Stouten Pharma Consultancy is located at Kempenarestraat 47, 2860 Sint-Katelijne-Waver.
When was the last time Stouten Pharma Consultancy filed their annual financial statements?
The most recent financial statements of Stouten Pharma Consultancy were filed on 02-07-2025.
How many employees does Stouten Pharma Consultancy have?
There are currently no employees working at Stouten Pharma Consultancy or no workforce information is available.
What is the annual turnover of Stouten Pharma Consultancy?
At the time of its most recent financial statements, Stouten Pharma Consultancy did not publish any turnover figures. Stouten Pharma Consultancy reported a gross margin of €159,450.36.